Process integration models for emerging challenges: Optimal allocation of antivirals under resource constraints

Abstract excerpt

The global scientific community has intensified efforts to develop, test, and commercialize pharmaceutical products to deal with the COVID-19 pandemic. Trials for both antivirals and vaccines are in progress; candidates include existing repurposed drugs that were originally developed for other ailments. Once these products are shown to be effective, their production will need to be ramped up rapidly to keep pace w...

Topics

Open a Topic to create a Post that cites this publication.

• Algorithms
• Artificial Intelligence
• Mutation
• Pandemics

Identifiers and source

Literature Corpus work

d6ce2cef-efd5-54e7-8e18-3d7b846a92ad

DOI

10.21203/rs.3.rs-24325/v1